Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Veeva Systems — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Veeva Systems trades at $284 (market cap $45.74B). The key difference: Veeva Systems is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Veeva Systems pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Veeva Systems for 5 Days on average.
| RPRX | VEEV | |
|---|---|---|
Market Cap | $25.27B | $45.74B |
Volume | 3,671,183 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $63.96 | $299.10 |
52-Week Low | $35.44 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $32.50B | $38.65B |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
